Akèy › Limfòm Non-Hodgkin › Kalifòni › Mountain View
Etid klinik pou Limfòm Non-Hodgkin nan Mountain View, CA
12 etid pou Limfòm Non-Hodgkin ap chèche patisipan nan sit nan ak bò kote Mountain View (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Ap rekriteFaz 1/2
- Stanford Medicine, Palo Alto · 5 mi lwen
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Ap rekriteFaz 2
- Sutter Palo Alto Medical Foundation: Palo Alto, Palo Alto · 5 mi lwen
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Ap rekriteFaz 1
- Stanford Medicine Cancer Center, Palo Alto · 5 mi lwen
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Ap rekriteFaz 3
- Stanford School of Medicine-Cancer Clinical Trials Office, Palo Alto · 5 mi lwen
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Ap rekriteEtid obsèvasyon
- Stanford University, Stanford · 5 mi lwen
DALY II USA/ MB-CART2019.1 for DLBCL
Ap rekriteFaz 2
- Stanford University, Stanford · 5 mi lwen
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- Stanford University Medical Center, Stanford · 5 mi lwen
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
Ap rekriteFaz 2
- Stanford, Stanford · 5 mi lwen
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Ap rekriteEtid obsèvasyon
- Stanford University School of Medicine, Stanford · 5 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Stanford · 5 mi lwen
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Ap rekriteEtid obsèvasyon
- Stanford University, School of Medicine, Palo Alto · 5 mi lwen
Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
Ap rekriteFaz 1
- Stanford University, Palo Alto · 5 mi lwen
Etid Limfòm Non-Hodgkin nan lòt vil
- New York City, NY31 etid
- Houston, TX31 etid
- Boston, MA26 etid
- Nashville, TN21 etid
- Philadelphia, PA20 etid
- Baldwin Park, CA19 etid
- Washington, DC18 etid
- Chicago, IL18 etid
- Milwaukee, WI18 etid
- Atlanta, GA18 etid
- Columbus, OH18 etid
- Dallas, TX17 etid
Lòt etid nan Mountain View
- Kansè (tout kalite)40 etid
- Kansè nan tete26 etid
- Kansè Metastatik25 etid
- Kansè Poumon ki pa ti selil21 etid
- Leksemi mieloïd egi19 etid
- Kansè ovè19 etid
- Twoub Spektòm Otis17 etid
- Kansè poumon17 etid
- Kansè pwostat15 etid
- Ensifizyans kadyak15 etid
- Otis13 etid
- Leksemi limfoblastik egi13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.